Rosetta Genomics Ltd. buy melinda
Start price
03.10.17
/
50%
€0.97
Target price
27.12.17
€1.35
Performance (%)
-48.91%
End price
27.12.17
€0.50
Summary
This prediction ended on 27.12.17 with a price of €0.50. Massive losses of -48.91% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rosetta Genomics Ltd. | - | - | - | - |
| iShares Core DAX® | 1.560% | 4.721% | 18.671% | 17.397% |
| iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% | 35.896% |
| iShares Nikkei 225® | 1.730% | 6.073% | 16.253% | 10.295% |
| iShares S&P 500 | 1.482% | 1.218% | 23.290% | 38.843% |
Comments by melinda for this prediction
In the thread Rosetta Genomics Ltd. diskutieren
Biotechnologie und medizinische SecteurRecherche
Rosetta Genomics Ltd. bietet therapeutische Leistungen, Produktentwicklung und medizinische Forschung. Das Unternehmen entwickelt und vermarktet neuartige diagnostische Tests basierend auf verschiedenen genomischen Markern, einschließlich DNA - Biomarker, microRNAs und Proteine und unter Verwendung verschiedener Technologien
(Vom Mitglied beendet)
Stopped prediction by melinda for Rosetta Genomics Ltd.
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.08
03.10.17
03.10.17
€1.50
27.12.17
27.12.17
-48.91%
27.12.17
27.12.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.33
17.05.17
17.05.17
€1.80
25.05.17
25.05.17
38.52%
25.05.17
25.05.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€2.40
07.04.17
07.04.17
€3.61
17.05.17
17.05.17
-40.39%
17.05.17
17.05.17